This page is part of the FHIR Specification (v0.0.82: DSTU 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)
{
"resourceType": "ValueSet",
"text": {
"status": "additional",
"div": "<div><p>Causality Observations</p>\r\n<table class=\"grid\">\r\n <tr><td><b>Code</b></td><td><b>Description</b></td><td><b>Version</b></td></tr>\r\n <tr><td>AW<a name=\"AW\"> </a></td><td>Abatement of event after product withdrawn</td><td>added v2.3</td></tr>\r\n <tr><td>BE<a name=\"BE\"> </a></td><td>Event recurred after product reintroduced</td><td>added v2.3</td></tr>\r\n <tr><td>DR<a name=\"DR\"> </a></td><td>Dose response observed</td><td>added v2.3</td></tr>\r\n <tr><td>EX<a name=\"EX\"> </a></td><td>Alternative explanations for the event available</td><td>added v2.3</td></tr>\r\n <tr><td>IN<a name=\"IN\"> </a></td><td>Event occurred after product introduced</td><td>added v2.3</td></tr>\r\n <tr><td>LI<a name=\"LI\"> </a></td><td>Literature reports association of product with event</td><td>added v2.3</td></tr>\r\n <tr><td>OE<a name=\"OE\"> </a></td><td>Occurrence of event was confirmed by objective evidence</td><td>added v2.3</td></tr>\r\n <tr><td>OT<a name=\"OT\"> </a></td><td>Other</td><td>added v2.3</td></tr>\r\n <tr><td>PL<a name=\"PL\"> </a></td><td>Effect observed when patient receives placebo</td><td>added v2.3</td></tr>\r\n <tr><td>SE<a name=\"SE\"> </a></td><td>Similar events in past for this patient</td><td>added v2.3</td></tr>\r\n <tr><td>TC<a name=\"TC\"> </a></td><td>Toxic levels of product documented in blood or body fluids</td><td>added v2.3</td></tr>\r\n</table>\r\n</div>"
},
"identifier": "http://hl7.org/fhir/v2/vs/0252",
"name": "v2 Causality Observations",
"publisher": "HL7, Inc",
"telecom": [
{
"system": "url",
"value": "http://hl7.org"
}
],
"description": "FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)",
"status": "active",
"date": "2011-01-28",
"define": {
"system": "http://hl7.org/fhir/v2/0252",
"caseSensitive": true,
"concept": [
{
"code": "AW",
"display": "Abatement of event after product withdrawn"
},
{
"code": "BE",
"display": "Event recurred after product reintroduced"
},
{
"code": "DR",
"display": "Dose response observed"
},
{
"code": "EX",
"display": "Alternative explanations for the event available"
},
{
"code": "IN",
"display": "Event occurred after product introduced"
},
{
"code": "LI",
"display": "Literature reports association of product with event"
},
{
"code": "OE",
"display": "Occurrence of event was confirmed by objective evidence"
},
{
"code": "OT",
"display": "Other"
},
{
"code": "PL",
"display": "Effect observed when patient receives placebo"
},
{
"code": "SE",
"display": "Similar events in past for this patient"
},
{
"code": "TC",
"display": "Toxic levels of product documented in blood or body fluids"
}
]
}
}